AKASA is a healthcare technology company founded in 2018, headquartered in South San Francisco, California. The firm operates at the intersection of generative AI and healthcare administration, having raised over $205 million in funding to date. Its client base spans all 50 US states, encompassing more than 650 hospitals and 6,500 outpatient facilities.
The company's core product is a generative AI platform built on large language models, designed to automate complex workflows within the healthcare revenue cycle. This platform integrates proprietary AI technology with domain expertise to handle processes including prior authorization, clinical documentation improvement (CDI), medical coding, and claims management.
AKASA positions itself as a specialist provider serving the financial and administrative backbone of healthcare delivery. Its focus on revenue cycle automation addresses a critical operational area for healthcare providers, where delays and errors in billing and coding directly impact financial performance.
